
My ePortfolio Register   

Inexpensive detector for prostate cancer cells on glass slides

Researchers have developed a new type of sensor that acts like glue for prostate cancer cells, sticking them to a modified frosted glass slide, like those used in science classes, so that they can be identified from blood samples.

The low-cost method, reported in ACS Applied Materials & Interfaces, could help doctors better diagnose and monitor the disease.

In men with prostate cancer, some tumour cells exit the prostate gland and circulate in the blood.

Detecting these cells could enable diagnosis at an earlier stage or help doctors assess whether treatment is effective.

However, because circulating tumour cells are present in very small numbers, finding them can be a challenge.

Previous sensors have been expensive and difficult to make.

So Shudong Zhang and Shutao Wang wanted do develop a simpler, more cost-effective way to monitor prostate cancer cells in the blood.

The researchers based their device on frosted glass microscope slides, commonplace in high school science classes.

The frosted area, which is used to hold and label the slide, is a sandblasted surface with tiny depressions.

The researchers added a solution to the frosted slides that caused silica nanowires to grow on their surfaces, then they dangled antibodies that recognized prostate cancer cells from the nanowires.

After getting captured by the antibodies, circulating tumour cells became trapped in the depressions on the slide and tangled up within the nanowires.

The team could then visualize the cancer cells with microscopy, and found that the device had a capture efficiency on par with other approaches, they say.

When the researchers tested blood samples from prostate cancer patients, the devices detected as few as 10 tumour cells in 1 millilitre of blood.

Source: American Chemical Society





Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence